Device Plastic Surgery

Mentor Memorygel Resterilizable Gel Sizer

Payments companies reported to CMS as associated with Mentor Memorygel Resterilizable Gel Sizer. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.5Massociated payments (2023-2025)

5,158clinicians with associated payments

6companies reporting

By year

2023 $449K

2024 $594K

2025 $447K

Payments reported as associated with Mentor Memorygel Resterilizable Gel Sizer, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Plastic Surgery $733K

Plastic and Reconstructive Surgery $404K

Physician Assistant $42K

Surgery $41K

Surgical $21K

Surgery of The Hand (Plastic Surgery) $14K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Mentor Memorygel Resterilizable Gel Sizer

These are the largest totals companies reported as associated with Mentor Memorygel Resterilizable Gel Sizer. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Brian Thornton	Louisville, KY	Plastic and Reconstructive Surgery	$63,896.74
Rahm Nazerali	Palo Alto, CA	Plastic Surgery	$56,526.48
Alexander Mericli	Houston, TX	Plastic Surgery	$43,367.74
Essie Kueberuwa Yates	Weston, FL	Plastic Surgery	$42,740.88
Aldona Spiegel	Houston, TX	Plastic and Reconstructive Surgery	$37,461.01
Samuel Lin	Boston, MA	Plastic Surgery	$33,043.79
Louis Strock	Fort Worth, TX		$31,864.46
Dennis Hammond	Grand Rapids, MI	Plastic Surgery	$26,434.92
Suzette Miranda	Seattle, WA	Plastic Surgery	$21,441.58
William Adams	Dallas, TX		$15,700.22

Prescribed Mentor Memorygel Resterilizable Gel Sizer?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.